Selim Salama, Heba Abdelhady, Lamiaa Atia


Fowl cholera (FC) and Avian Influenza (AI) are two of the major economically important respiratory and septicaemic disease of poultry in Egypt and allover the world. A field trails was conducted to evaluate the immunogenicity of an experimentally multivalent inactivated Fowl cholera (P. multocida) and Avian Influenza (H9N2) vaccine. The In this study a combined inactivated Montanide ISA fowl cholera and AI vaccine was prepared then the immunization potency and protective efficacy were evaluated through experimental application on different poultry breeds including broiler breeder, broiler and turkey flocks.The peak of humeral immune response against P. multocida as measured by ELISA was at the 5th week post vaccination and at 3rd week post boostering all over the used poultry flocks. At the same time, AI immune response as measured by HI reached the peak at the 6th week post vaccination and at 2nd week post boostering. Regarding the challenge test, the protection levels were 76.6, 70 and 80% and 90, 86.6 and 93.3% against P. multocida while protection levels were 83.3, 80 and 86.6% and 93.3, 90 and 96.6% against AI virus after challenge with the used virulent strains post single and booster dose respectively. In conclusion the combined prepared fowl cholera and AI vaccine succeeded in eliciting protective antibody titres and full protection against both fowl cholera and AI diseases.

Key words: Pasteurella multocida; AI; vaccine; ELISA; PHA; HI; challenge test

Full Text:



Glisson, J.R., C.L. Hofacre and J.P. Christensen. Fowl cholera. In: Diseases of poul-try, Saif YM, Barenes HJ, Glisson JR, Fadly AM, McDougald LR and Swayne DE (Editors). Blackwell Publishing, Ames, Iowa, USA, 2008; 739–58.

Swayne, D.E. and D.A. Halvorson. Avian influenza. In: Saif, Y.M., Barnes, H.J., Fadly, A.M., Glisson, J.R., McDougald, L.R., Swayne, D.E. (Eds.). Diseases of Poultry. 11th ed. Iowa State Press, Iowa. 2003; pp. 135–60.

Adler, B., D. Bulach, J. Chung, S. Doughty, M. Hunt, K. Rajakumar, M. Serrano, A. Van Zanden, Y. Zhang and C. Ruffolo. Can-didate vaccine antigen and genes in Pasteurella multocida. J. Biotech. 1999; 73(2-3): 83–90.

Takai, H., Y. Hayakawa, E. Shintani, H. Komae, Y. Yoshida, H. Ide, G. Abe and T. Sawada. The first outbreak of P.multocida. in-fection in turkeys in Japan. J. Japan Vet. Med. Association, 1994; 47:923–7.

Voyles, B.A. Orthomyxoviruses. In: The biology of viruses 2nd Ed. New York, NY: McGraw-Hill, 147. 2002.

Alexander, D. J. Should We Change the Definition of Avian Influenza for Eradication Purposes? Avian Diseases. 2003; 47: 976–81.

Bano, S., K. Naeem and S.A. Malik. Evaluation of Pathogenic Potential of Avian Influenza Virus Serotype H9N2 in Chickens. Avian Diseases. 2003; 47:817–22.

Alexander, D. J. A review of avian in-fluenza in different bird species. Vet. Microbi-ol. 2000; 74 (1 -2): 3–13.

Orabi A, Hussein A, Saleh A A, El-Magd M A, Munir M. Evolutionary insights into the fusion protein of Newcastle disease virus isolated from vaccinated chickens in 2016 in Egypt, Archives of Virology 2017; 162(10): 3069–79

Reddy, G.S.; K. Ananda and V.A. Srinivasan. Performance of oil adjuvant com-bined vaccine cintaining FMD, Rabies, Pas-teurella multocida and Clostridium chauvoei antigens. Indian Veterinary Journal, 2001; 78(11): 990–3.

Swayne, D.E.; D.A. Senne and C.W. Beard. Influenza, in: Swayne, D.E.; Glisson, J.R.; Jackwood, M.W.; Pearson, J.E. and Reed, W.M. (Eds), Isolation and identification of avi-an pathogens: Kennet Square: American Asso-ciation of Avian Pathologist. 1998; 150–5.

Villegas, P. 1998. Titration of biological suspensions. In: Swayne, D.E. (Ed), A Labora-tory Manual for the Isolation and Identification of Avian Pathogens, fourth ed. American Asso-ciation of Avian Pathologists, Kennett Square, PA, 1998; 248–54.

Sarachai, C.; J. Sasipreeyajan, and N. Chansiripornchai. Avian Influenza virus (H5N1) inactivation by Binary Ethylenimine. Thai J. Vet. Med. 2010; 40(1): 41–6.

OIE. Manual of Standars of Diagnostic Tests and Vaccines for Terrestrial Animals Safety Test, 2017; chapter, 2.3.4., Avian influ-enza page no.446.

Jabbri, A. R. and G.R. Moazeni Jula. Fowl cholera: Evaluation of a Trivalent Pas-teurella multocida Vaccine Consisted of Sero-types 1, 3 and 4. Arch. Razi Ins. 2005; 59: 103–11.

Kwon, J.S.; H.J. Lee, D.H. Lee, Y.J. Lee, I.P. Mo, S.S. Nahm, M.J. Kim, J.B. Lee, S.Y. Park, I.S. Choi and C.S. Song. Immune response and pathogenesis in immunocompro-mised chickens in response to infection with the H9N2 low pathogenic avian influenza virus. Virus Research, 2008; 133: 187-–94.

Stone, D.; M. Brugh, S.R. Hophins, H.W. Yoder and C.W. Peard. Preparation of inactivated oil emulsion vaccines wiyh avian viral or Mycoplasma antigens. Avian Dis., 1978; 22: 666–47.

Parvin, M.S., M. P. Siddique and M. T. Islam. Humoral immune response to fowl chol-era vaccine in different breeds of commercial birds Bangl. J. Vet. Med. 2011; 9 (2): 127 –31.

Iqbal, M.T.; M.H. Haque, S. Sarker, M.A. Islam and K.A. Choudhury. Determina-tion of immune response against alum- precipi-tated fowl cholera vaccine in the quail, coturnix japonica. Univ. J. Zool. Rajshahi. 2010; 29: 57–60.

Belloc, C.; L. Dupuis, S. Deville, H. Aucouturier and A. Laval. Evaluation of safety and immune response induced by several adju-vants included in Pasteurella multocida vac-cines in chickens. Revue Méd. Vét., 2008; 159(7): 371–5.

Lin, Y. J.; M. C. Deng, S. H. Wu, Y. L. Chen, H. C. Cheng, C. Y. Chang, M. S. Lee, M. S. Chien and C.C. Huang. Baculovirus-Derived Hemagglutinin Vaccine Protects Chickens from Lethal Homologous Virus H5N1 Challenge. J. Vet. Med. Sci. 2008; 70(11): 1147–52.

Rajabi, Z.; H.T. Nasrabadi and A.B. Sy-ofi-Khojin. Evaluation the quality of oil-Emulsion Avian Influenza subgroup H9N2 vac-cines in in-vitro. Vaccinology, 2010; 2: 22–5.

Liu, C.G.; Ming Liu, Fei Liu, Da F Liu, Yun Zhang, Wei Q Pan, Hao Chen, Chun H Wan, En C Sun, Hong T Li, and Wen H Xiang. Evaluation of several adjuvants in avian influ-enza vaccine to chickens and ducks. Virol J.; 2011; 8: 321.

Lee, D.H.; J.S. Kwon, H.J. Lee, Y.N. Lee, W. Hur, Y.H. Hong, J.B. Lee, S.Y. Park, I.S. Choi and C.S. Song. Inactivated H9N2 avi-an influenza virus vaccine with gel-primed and mineral oil- boosted regimen could produce improved immune response in broiler breeders. Poultry Science, 2011; 90: 1020–2.

Elham, A. youssef; Eman, A. Hassan; Mervata, A. El-Koffy and A.M. Daoud. Trial for preparation of combined oil inactivated vaccine against Newcastle and Fowl Cholera diseases by using Montanide ISA 206 oil for improving the immune response in chickens. Vet. Med. J. Giza, 2005; 53 (2): 341–52.

Hala, A.F.; I.S. Ibrahim, H.G. Fawzy and S.M. Aboul Saoud. Preparation and evalua-tion of avian cholera oil emulsion vaccine using Montanide ISA 206. Egypt. Vet. Med. Assoc., 2002; 62(2).

Jun G. C.; J.L. Youn, J.K. Yong, K.L. Eun, O.M. Jeong, W.S. Haan, H.K. Jae and H.K. Jun. An inactivated vaccine to control the current H9N2 low pathogenic avianinfluenza in Korea. J. Vet. Sci., 2008; 9(1): 67–74.

Dungu, B.; B. Brett, R. Macdonald, S. Deville, L. Dupuis, J. Theron and R.R. Bragg. Study on the efficacy and safety of different antigens and oil formulations of infectious co-ryza vaccines containing an NAD-independent strain of Avibacterium paragallinarum. Onder-stepoort Journal of Veterinary Research, 2009; 76:299–309.

Fatma Elzahraa G. AboElkhir, Afaf A. Khedr and Elseedy F R. Identity of Pasteurella multocida and Avian Influenza H9N2 Strains Used in Preparation of a Combined Inactivated Vaccine Using PCR. Global Veterinaria 2005; 14 (4): 535–8.



  • There are currently no refbacks.

Gerbičeva 60, SI-1000 Ljubljana, Slovenia, T: +386 (0)1 47 79 100, F: +386 (0)1 28 32 243, E:
Published by